Licensing Application News Today

There have been several changes to the pharmaceutical and biotech regulatory landscape in 2023. The short and long-term impacts of these changes are relatively unknown; however, all could shape the regulatory landscape for life sciences in 2024 and beyond.What are the regulatory changes?Reform of the European Union&...

Bluebird bio, Inc. announced that new long-term efficacy, safety and health-related quality of life follow-up data from its lentiviral vector gene therapy programs in patients with sickle cell...

Message from the Chairman of the Board chris mcfadden Dear Fellow Shareholders, You are invited to attend the Annual General and Special Meeting of Shareholders ... | May 8, 2023

NLA Banker To Banker Swoops In Cape Coast; 7 Arrested And Arraigned Before Court

NLA Banker To Banker Swoops In Cape Coast; 7 Arrested And Arraigned Before Court

Share this article Share this article LOS ANGELES, April 12, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against bluebird bio, Inc. ("bluebird" or "the Company") (NASDAQ: BLUE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Companys securities between May 11, 202...

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of bluebird bio, Inc. (NASDAQ: BLUE) between May...

DEADLIINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against bluebird bio, Inc. and Encourages Investors to Contact the Firm April 09, 2021 21:00 ET | Source: Bragar Eagel & Squire Bragar Eagel & Squire New York, New York, UNITED STATES NEW YORK, April 09, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, Reminds Investors that a class actio...

Home / Top News / BLUE FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages bluebird bio, Inc. Investors With Losses to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – BLUE BLUE FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages bluebird bio, Inc. Investors With Losses to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – BLUE NEW YORK, April 09, 2021 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rig...

Search jobs 07-Apr-2021 DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against bluebird bio, Inc. and Encourages Investors to Contact the Firm NEW YORK--(BUSINESS WIRE)--#bluebirdbio--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, Reminds Investors that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts...